2015;66:791 800. 24. Lytvyn L, Guyatt GH, Manja V, et al. Patient values and preferences on transcatheter or surgical aortic valve replacement therapy for aortic steno- sis: a systematic review. BMJ Open. 2016;6:e014327. 25. Otto CM, Kumbhani DJ, Alexander KP, et al. 2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the man- agement of adults with aortic stenosis: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2017;69:1313 46. 26. Abdel-Wahab M, Landt M, Neumann FJ, et al. 5-Year outcomes af- ter TAVR with balloon-expandable versus self-expanding valves: results from the CHOICE Randomized Clinical Trial. JACC Cardiovasc Interv. 2020;13:1071 82. 27. Deharo P, Bisson A, Herbert J, et al. Impact of Sapien 3 balloon-expandable versus Evolut R self-expandable transcatheter aortic valve implantation in patients with aortic stenosis: data from a nationwide analysis. Circulation. 2020;141:260 8. 28. Van Belle E, Vincent F, Labreuche J, et al. Balloon-expandable versus self- expanding transcatheter aortic valve replacement: a propensity-matched comparison from the FRANCE-TAVI Registry. Circulation. 2020;141:243 59. 29. Furer A, Chen S, Redfors B, et al. Effect of baseline left ventricular ejection fraction on 2-year outcomes after transcatheter aortic valve replacement: analysis of the PARTNER 2 trials. Circ Heart Fail. 2019;12:e005809. 30. Ribeiro HB, Lerakis S, Gilard M, et al. Transcatheter aortic valve replace- ment in patients with low-flow, low-gradient aortic stenosis: the TOPAS- TAVI registry. J Am Coll Cardiol. 2018;71:1297 308. 31. Schewel J, Schl ter M, Schmidt T, et al. Early haemodynamic changes and long-term outcome of patients with severe low-gradient aortic stenosis after transcatheter aortic valve replacement. EuroIntervention. 2020;15:1181 9. 32. Maes F, Lerakis S, Barbosa Ribeiro H, et al. 